The current valuation score of Revolution Medicines Inc is 9.00, ranking 67 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -26.46, which is -78.75% below the recent high of -5.62 and -2.42% above the recent low of -27.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.